Veterinary Molecular Diagnostics Market By Product; Technology; Animal Type; Disease Indication and End User; - Global Industry Analysis And Forecast To 2027
Published On : November 2018 Pages : 150 Category: Pharma & Healthcare Report Code : HC121948
Veterinary Molecular Diagnostics Market By Product (Services, Instruments & Software and Kits & Reagents); Technology (DNA Sequencing, Polymerase Chain Reaction (PCR) and Microarrays); Animal Type (Livestock Animals and Companion Animals); Disease Indication (Diarrhea Pathogens Detection, Vector-borne Diseases, Respiratory Pathogens Detection and Others) and End User (Reference Laboratories and Hospitals/Clinics); - Global Industry Analysis And Forecast To 2027
Category – Healthcare
Industry Outlook
Veterinary Molecular Diagnostics is the field where samples from animals are tested for any disorder. Veterinary Molecular Diagnostics mainly deals with detecting, identifying and genotyping of bacteria, virus and other microorganisms. Techniques used for molecular diagnostics are mostly similar to that used for humans. Veterinary Molecular Diagnostics focuses of diagnosis of disease in particular animal or herd of animals and also get the status of diseases in herd. The use for Veterinary Molecular Diagnostics services is growing due to; considerable growth in farm animal sector & increase in the animal healthcare sector, attitude of people towards pet animals, rising demand for technically advanced techniques as compared to conventional techniques, increasing focus on prevention & curing of various diseases in animals by veterinaries, rising pet animal ownership culture across the globe, increasing consumption of animal meat, increasing demand for pet insurance, etc. Therefore, the Veterinary Molecular Diagnostics Market is anticipated to expand and has tremendous scope during the forecast period. The global Veterinary Molecular Diagnostics Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Veterinary Molecular Diagnostics Market is based on segment, by Product the market is segmented into Services, Instruments & Software and Kits & Reagents; by Technology the market is segmented into DNA Sequencing, Polymerase Chain Reaction (PCR) and Microarrays; by Animal Type the market is segmented into Livestock Animals and Companion Animals; by Disease Indication the market is segmented into Diarrhea Pathogens Detection, Vector-borne Diseases, Respiratory Pathogens Detection and Others; and by End User the market is segmented into Reference Laboratories and Hospitals/Clinics.
- Veterinary Molecular Diagnostics Market, By Product
- Services
- Instruments & Software
- Kits & Reagents
- Veterinary Molecular Diagnostics Market, By Technology
- DNA Sequencing
- Polymerase Chain Reaction (PCR)
- Microarrays
- Veterinary Molecular Diagnostics Market, By Animal Type
- Livestock Animals
- Companion Animals
- Veterinary Molecular Diagnostics Market, By Disease Indication
- Diarrhea Pathogens Detection
- Vector-borne Diseases
- Respiratory Pathogens Detection
- Others
- Veterinary Molecular Diagnostics Market, By End User
- Reference Laboratories
- Hospitals/Clinics
Regional Insights
On a global front, the Veterinary Molecular Diagnostics Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Veterinary Molecular Diagnostics Market due to; rising number of animals, growth in food from animals, more income used for animal health care, etc.
Veterinary Molecular Diagnostics Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Biomedica Medizinprodukte GmbH & Co KG, QIAGEN N.V., VCA Inc., HealthGene Corporation, Thermo Fisher Scientific Inc., Bioneer, IDEXX Laboratories Inc., Novacyt Group, Veterinary Molecular Diagnostics, Inc., GE Healthcare, Zoetis, Inc., Heska Corporation, ABAXIS Inc., Neogen Corporation, ID.Vet, Virbac and AGFA Healthcare. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Biomedica Medizinprodukte GmbH & Co KG
- QIAGEN N.V.
- VCA Inc.
- HealthGene Corporation
- Thermo Fisher Scientific Inc.
- Bioneer
- IDEXX Laboratories Inc.
- Novacyt Group
- Veterinary Molecular Diagnostics, Inc.
- GE Healthcare
- Zoetis, Inc.
- Heska Corporation
- ABAXIS Inc.
- Neogen Corporation
- ID.Vet
- Virbac
- AGFA Healthcare
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Veterinary Molecular Diagnostics Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Services
o Instruments & Software
o Kits & Reagents
o Veterinary Molecular Diagnostics Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o DNA Sequencing
o Polymerase Chain Reaction (PCR)
o Microarrays
o Veterinary Molecular Diagnostics Market, By Animal Type, Estimates and Forecast, 2017-2027 ($Million)
o Livestock Animals
o Companion Animals
o Veterinary Molecular Diagnostics Market, By Disease Indication, Estimates and Forecast, 2017-2027 ($Million)
o Diarrhea Pathogens Detection
o Vector-borne Diseases
o Respiratory Pathogens Detection
o Others
o Veterinary Molecular Diagnostics Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Reference Laboratories
o Hospitals/Clinics
Veterinary Molecular Diagnostics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Veterinary Molecular Diagnostics Market, By Country
o U.S. Veterinary Molecular Diagnostics Market
o Canada Veterinary Molecular Diagnostics Market
o Mexico Veterinary Molecular Diagnostics Market
o Europe
§ Europe Veterinary Molecular Diagnostics Market, By Country
o Germany Veterinary Molecular Diagnostics Market
o UK Veterinary Molecular Diagnostics Market
o France Veterinary Molecular Diagnostics Market
o Russia Veterinary Molecular Diagnostics Market
o Italy Veterinary Molecular Diagnostics Market
o Rest of Europe Veterinary Molecular Diagnostics Market
o Asia-Pacific
§ Asia-Pacific Veterinary Molecular Diagnostics Market, By Country
o China Veterinary Molecular Diagnostics Market
o Japan Veterinary Molecular Diagnostics Market
o South Korea Veterinary Molecular Diagnostics Market
o India Veterinary Molecular Diagnostics Market
o Southeast Asia Veterinary Molecular Diagnostics Market
o Rest of Asia-Pacific Veterinary Molecular Diagnostics Market
o South America
§ South America Veterinary Molecular Diagnostics Market, By Country
o Brazil Veterinary Molecular Diagnostics Market
o Argentina Veterinary Molecular Diagnostics Market
o Columbia Veterinary Molecular Diagnostics Market
o Rest of South America Veterinary Molecular Diagnostics Market
o Middle East and Africa
§ Middle East and Africa Veterinary Molecular Diagnostics Market, By Country
o Saudi Arabia Veterinary Molecular Diagnostics Market
o UAE Veterinary Molecular Diagnostics Market
o Egypt Veterinary Molecular Diagnostics Market
o Nigeria Veterinary Molecular Diagnostics Market
o South Africa Veterinary Molecular Diagnostics Market
o Rest of MEA Veterinary Molecular Diagnostics Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2027)
4.1.2. Canada Market States and Outlook (2017-2027)
4.1.3. Mexico Market States and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2027)
4.2.2. France Market States and Outlook (2017-2027)
4.2.3. UK Market States and Outlook (2017-2027)
4.2.4. Russia Market States and Outlook (2017-2027)
4.2.5. Italy Market States and Outlook (2017-2027)
4.2.6. Rest of Europe Market States and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2027)
4.3.2. Japan Market States and Outlook (2017-2027)
4.3.3. Korea Market States and Outlook (2017-2027)
4.3.4. India Market States and Outlook (2017-2027)
4.3.5. Southeast Asia Market States and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market States and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2027)
4.4.2. Argentina Market States and Outlook (2017-2027)
4.4.3. Columbia Market States and Outlook (2017-2027)
4.4.4. Rest of South America Market States and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2027)
4.5.2. United Arab Emirates Market States and Outlook (2017-2027)
4.5.3. Egypt Market States and Outlook (2017-2027)
4.5.4. Nigeria Market States and Outlook (2017-2027)
4.5.5. South Africa Market States and Outlook (2017-2027)
4.5.6. Turkey Market States and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market States and Outlook (2017-2027)
5. Veterinary Molecular Diagnostics Market, By Product
5.1. Introduction
5.2. Global Veterinary Molecular Diagnostics Revenue and Market Share by Product (2017-2027)
5.2.1. Global Veterinary Molecular Diagnostics Revenue and Revenue Share by Product (2017-2027)
5.3. Services
5.3.1. Global Services Revenue and Growth Rate (2017-2027)
5.4. Instruments & Software
5.4.1. Global Instruments & Software Revenue and Growth Rate (2017-2027)
5.5. Kits & Reagents
5.5.1. Global Kits & Reagents Revenue and Growth Rate (2017-2027)
6. Veterinary Molecular Diagnostics Market, By Technology
6.1. Introduction
6.2. Global Veterinary Molecular Diagnostics Revenue and Market Share by Technology (2017-2027)
6.2.1. Global Veterinary Molecular Diagnostics Revenue and Revenue Share by Technology (2017-2027)
6.3. DNA Sequencing
6.3.1. Global DNA Sequencing Revenue and Growth Rate (2017-2027)
6.4. Polymerase Chain Reaction (PCR)
6.4.1. Global Polymerase Chain Reaction (PCR) Revenue and Growth Rate (2017-2027)
6.5. Microarrays
6.5.1. Global Microarrays Revenue and Growth Rate (2017-2027)
7. Veterinary Molecular Diagnostics Market, By Animal Type
7.1. Introduction
7.2. Global Veterinary Molecular Diagnostics Revenue and Market Share by Animal Type (2017-2027)
7.2.1. Global Veterinary Molecular Diagnostics Revenue and Revenue Share by Animal Type (2017-2027)
7.3. Livestock Animals
7.3.1. Global Livestock Animals Revenue and Growth Rate (2017-2027)
7.4. Companion Animals
7.4.1. Global Companion Animals Revenue and Growth Rate (2017-2027)
8. Veterinary Molecular Diagnostics Market, By Disease Indication
8.1. Introduction
8.2. Global Veterinary Molecular Diagnostics Revenue and Market Share by Disease Indication (2017-2027)
8.2.1. Global Veterinary Molecular Diagnostics Revenue and Revenue Share by Disease Indication (2017-2027)
8.3. Diarrhea Pathogens Detection
8.3.1. Global Diarrhea Pathogens Detection Revenue and Growth Rate (2017-2027)
8.4. Vector-borne Diseases
8.4.1. Global Vector-borne Diseases Revenue and Growth Rate (2017-2027)
8.5. Respiratory Pathogens Detection
8.5.1. Global Respiratory Pathogens Detection Revenue and Growth Rate (2017-2027)
8.6. Others
8.6.1. Global Others Revenue and Growth Rate (2017-2027)
9. Veterinary Molecular Diagnostics Market, By End User
9.1. Introduction
9.2. Global Veterinary Molecular Diagnostics Revenue and Market Share by End User (2017-2027)
9.2.1. Global Veterinary Molecular Diagnostics Revenue and Revenue Share by End User (2017-2027)
9.3. Reference Laboratories
9.3.1. Global Reference Laboratories Revenue and Growth Rate (2017-2027)
9.4. Hospitals/Clinics
9.4.1. Global Hospitals/Clinics Revenue and Growth Rate (2017-2027)
10. Veterinary Molecular Diagnostics Market, By Region
10.1. Introduction
10.2. Global Veterinary Molecular Diagnostics Revenue and Market Share by Regions
10.2.1. Global Veterinary Molecular Diagnostics Revenue by Regions (2017-2027)
10.3. North America Veterinary Molecular Diagnostics by Countries
10.3.1. North America Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2027)
10.3.2. North America Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2027)
10.3.3. United States
10.3.3.1. United States Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.3.4. Canada
10.3.4.1. Canada Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.3.5. Mexico
10.3.5.1. Mexico Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4. Europe Veterinary Molecular Diagnostics by Countries
10.4.1. Europe Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2027)
10.4.2. Europe Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2027)
10.4.3. Germany
10.4.3.1. Germany Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.4. France
10.4.4.1. France Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.5. UK
10.4.5.1. UK Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.6. Russia
10.4.6.1. Russia Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.7. Italy
10.4.7.1. Italy Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.8. Rest of Europe
10.4.8.1. Rest of Europe Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5. Asia-Pacific Veterinary Molecular Diagnostics by Countries
10.5.1. Asia-Pacific Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2027)
10.5.2. Asia-Pacific Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2027)
10.5.3. China
10.5.3.1. China Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.4. Japan
10.5.4.1. Japan Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.5. Korea
10.5.5.1. Korea Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.6. India
10.5.6.1. India Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.7. Southeast Asia
10.5.7.1. Southeast Asia Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.8. Rest of Asia-Pacific
10.5.8.1. Rest of Asia-Pacific Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.6. South America Veterinary Molecular Diagnostics by Countries
10.6.1. South America Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2027)
10.6.2. South America Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2027)
10.6.3. Brazil
10.6.3.1. Brazil Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.4. Argentina
10.6.4.1. Argentina Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.5. Columbia
10.6.5.1. Columbia Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.6. Rest of South America
10.6.6.1. Rest of South America Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7. Middle East and Africa Veterinary Molecular Diagnostics by Countries
10.7.1. Middle East and Africa Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2027)
10.7.2. Middle East and Africa Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2027)
10.7.3. Saudi Arabia
10.7.3.1. Saudi Arabia Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.4. United Arab Emirates
10.7.4.1. United Arab Emirates Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.5. Egypt
10.7.5.1. Egypt Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.6. Nigeria
10.7.6.1. Nigeria Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.7. South Africa
10.7.7.1. South Africa Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.8. Turkey
10.7.8.1. Turkey Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.9. Rest of Middle East and Africa
10.7.9.1. Rest of Middle East and Africa Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
11. Company Profiles
11.1. Biomedica Medizinprodukte GmbH & Co KG
11.1.1. Business Overview
11.1.2. Service Portfolio
11.1.3. Strategic Developments
11.1.4. Revenue and Market Share
11.2. QIAGEN N.V.
11.2.1. Business Overview
11.2.2. Service Portfolio
11.2.3. Strategic Developments
11.2.4. Revenue and Market Share
11.3. VCA Inc.
11.3.1. Business Overview
11.3.2. Service Portfolio
11.3.3. Strategic Developments
11.3.4. Revenue and Market Share
11.4. HealthGene Corporation
11.4.1. Business Overview
11.4.2. Service Portfolio
11.4.3. Strategic Developments
11.4.4. Revenue and Market Share
11.5. Thermo Fisher Scientific Inc.
11.5.1. Business Overview
11.5.2. Service Portfolio
11.5.3. Strategic Developments
11.5.4. Revenue and Market Share
11.6. Bioneer
11.6.1. Business Overview
11.6.2. Service Portfolio
11.6.3. Strategic Developments
11.6.4. Revenue and Market Share
11.7. IDEXX Laboratories Inc.
11.7.1. Business Overview
11.7.2. Service Portfolio
11.7.3. Strategic Developments
11.7.4. Revenue and Market Share
11.8. Novacyt Group
11.8.1. Business Overview
11.8.2. Service Portfolio
11.8.3. Strategic Developments
11.8.4. Revenue and Market Share
11.9. Veterinary Molecular Diagnostics, Inc.
11.9.1. Business Overview
11.9.2. Service Portfolio
11.9.3. Strategic Developments
11.9.4. Revenue and Market Share
11.10. GE Healthcare
11.10.1. Business Overview
11.10.2. Service Portfolio
11.10.3. Strategic Developments
11.10.4. Revenue and Market Share
11.11. Zoetis, Inc.
11.11.1. Business Overview
11.11.2. Service Portfolio
11.11.3. Strategic Developments
11.11.4. Revenue and Market Share
11.12. Heska Corporation
11.12.1. Business Overview
11.12.2. Service Portfolio
11.12.3. Strategic Developments
11.12.4. Revenue and Market Share
11.13. ABAXIS Inc.
11.13.1. Business Overview
11.13.2. Service Portfolio
11.13.3. Strategic Developments
11.13.4. Revenue and Market Share
11.14. Neogen Corporation
11.14.1. Business Overview
11.14.2. Service Portfolio
11.14.3. Strategic Developments
11.14.4. Revenue and Market Share
11.15. ID.Vet
11.15.1. Business Overview
11.15.2. Service Portfolio
11.15.3. Strategic Developments
11.15.4. Revenue and Market Share
11.16. Virbac
11.16.1. Business Overview
11.16.2. Service Portfolio
11.16.3. Strategic Developments
11.16.4. Revenue and Market Share
11.17. AGFA Healthcare
11.17.1. Business Overview
11.17.2. Service Portfolio
11.17.3. Strategic Developments
11.17.4. Revenue and Market Share
12. Global Veterinary Molecular Diagnostics Market Competition, by Manufacturer
12.1. Global Veterinary Molecular Diagnostics Revenue and Market Share by Manufacturer (2017-2017)
12.2. Global Veterinary Molecular Diagnostics Price By Region (2017-2017)
12.3. Top 5 Veterinary Molecular Diagnostics Manufacturer Market Share
12.4. Market Competition Trend
13. Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.1. Global Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2027)
13.2. Veterinary Molecular Diagnostics Market Forecast by Regions (2017-2027)
13.2.1. North America Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.1.1. United States Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.1.2. Canada Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.1.3. Mexico Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.2. Europe Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.2.1. Germany Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.2.2. France Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.2.3. UK Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.2.4. Russia Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.2.5. Italy Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.2.6. Rest of Europe Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.3. Asia-Pacific Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.3.1. China Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.3.2. Japan Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.3.3. Korea Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.3.4. India Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.3.5. Southeast Asia Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.3.6. Rest of Asia-Pacific Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.4. South America Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.4.1. Brazil Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.4.2. Argentina Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.4.3. Columbia Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.4.4. Rest of South America Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.5. Middle East and Africa Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.5.1. Saudi Arabia Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.5.2. United Arab Emirates Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.5.3. Egypt Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.5.4. Nigeria Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.5.5. South Africa Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.5.6. Turkey Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.2.5.7. Rest of Middle East and Africa Veterinary Molecular Diagnostics Market Forecast (2017-2027)
13.3. Veterinary Molecular Diagnostics Market Forecast by Product (2017-2027)
13.3.1. Veterinary Molecular Diagnostics Forecast by Product (2017-2027)
13.3.2. Veterinary Molecular Diagnostics Market Share Forecast by Product (2017-2027)
13.4. Veterinary Molecular Diagnostics Market Forecast by Technology (2017-2027)
13.4.1. Veterinary Molecular Diagnostics Forecast by Technology (2017-2027)
13.4.2. Veterinary Molecular Diagnostics Market Share Forecast by Technology (2017-2027)
13.5. Veterinary Molecular Diagnostics Market Forecast by Animal Type (2017-2027)
13.5.1. Veterinary Molecular Diagnostics Forecast by Animal Type (2017-2027)
13.5.2. Veterinary Molecular Diagnostics Market Share Forecast by Animal Type (2017-2027)
13.6. Veterinary Molecular Diagnostics Market Forecast by Disease Indication (2017-2027)
13.6.1. Veterinary Molecular Diagnostics Forecast by Disease Indication (2017-2027)
13.6.2. Veterinary Molecular Diagnostics Market Share Forecast by Disease Indication (2017-2027)
13.7. Veterinary Molecular Diagnostics Market Forecast by End User (2017-2027)
13.7.1. Veterinary Molecular Diagnostics Forecast by End User (2017-2027)
13.7.2. Veterinary Molecular Diagnostics Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Veterinary Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Veterinary Molecular Diagnostics Revenue and Revenue Share by Product (2017-2018)
Figure Global Services Revenue and Growth Rate (2017-2018)
Figure Global Instruments & Software Revenue and Growth Rate (2017-2018)
Figure Global Kits & Reagents Revenue and Growth Rate (2017-2018)
Table Global Veterinary Molecular Diagnostics Revenue and Revenue Share by Technology (2017-2018)
Figure Global DNA Sequencing Revenue and Growth Rate (2017-2018)
Figure Global Polymerase Chain Reaction (PCR) Revenue and Growth Rate (2017-2018)
Figure Global Microarrays Revenue and Growth Rate (2017-2018)
Table Global Veterinary Molecular Diagnostics Revenue and Revenue Share by Animal Type (2017-2018)
Figure Global Livestock Animals Revenue and Growth Rate (2017-2018)
Figure Global Companion Animals Revenue and Growth Rate (2017-2018)
Table Global Veterinary Molecular Diagnostics Revenue and Revenue Share by Disease Indication (2017-2018)
Figure Global Diarrhea Pathogens Detection Revenue and Growth Rate (2017-2018)
Figure Global Vector-borne Diseases Revenue and Growth Rate (2017-2018)
Figure Global Respiratory Pathogens Detection Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Veterinary Molecular Diagnostics Revenue and Revenue Share by End User (2017-2018)
Figure Global Reference Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Hospitals/Clinics Revenue and Growth Rate (2017-2018)
Table Global Veterinary Molecular Diagnostics Revenue by Regions (2017-2018)
Figure North America Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure North America Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2018)
Figure North America Veterinary Molecular Diagnostics by Countries (2017-2018)
Figure North America Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure United States Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure United States Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Canada Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Mexico Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Europe Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2018)
Figure Europe Veterinary Molecular Diagnostics by Countries (2017-2018)
Figure Europe Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Germany Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure France Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure UK Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Russia Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Italy Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Rest of Europe Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Asia-Pacific Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Veterinary Molecular Diagnostics by Countries (2017-2018)
Figure Asia-Pacific Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure China Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure China Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Japan Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Korea Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure India Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Southeast Asia Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure South America Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2018)
Figure South America Veterinary Molecular Diagnostics by Countries (2017-2018)
Figure South America Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Brazil Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Argentina Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Columbia Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Rest of South America Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Middle East and Africa Veterinary Molecular Diagnostics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Veterinary Molecular Diagnostics by Countries (2017-2018)
Figure Middle East and Africa Veterinary Molecular Diagnostics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Saudi Arabia Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure United Arab Emirates Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Egypt Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Nigeria Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure South Africa Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Turkey Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Veterinary Molecular Diagnostics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2018)
Table Biomedica Medizinprodukte GmbH & Co KG Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table QIAGEN N.V. Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table VCA Inc. Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table HealthGene Corporation Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fisher Scientific Inc. Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bioneer Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table IDEXX Laboratories Inc. Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novacyt Group Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Veterinary Molecular Diagnostics, Inc. Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GE Healthcare Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Zoetis, Inc. Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Heska Corporation Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ABAXIS Inc. Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Neogen Corporation Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ID.Vet Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Virbac Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AGFA Healthcare Veterinary Molecular Diagnostics Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Veterinary Molecular Diagnostics Market Share by Manufacturer
Figure Global Veterinary Molecular Diagnostics Revenue and Market Share by Manufacturer
Table Global Veterinary Molecular Diagnostics Price by Region (2017-2017)
Figure Top 5 Veterinary Molecular Diagnostics Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Veterinary Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Veterinary Molecular Diagnostics Market Forecast by Regions (2018-2025)
Figure North America Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure United States Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Canada Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Mexico Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Europe Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Germany Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure France Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure UK Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Russia Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Italy Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Rest of Europe Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Asia-Pacific Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure China Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Japan Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Korea Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure India Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Southeast Asia Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure South America Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Brazil Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Argentina Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Columbia Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Rest of South America Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Middle East and Africa Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Saudi Arabia Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure United Arab Emirates Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Egypt Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Nigeria Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure South Africa Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Turkey Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Veterinary Molecular Diagnostics Market Forecast (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by Product (2018-2025)
Figure Global Veterinary Molecular Diagnostics Market Share Forecast by Product (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by Product (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by Technology (2018-2025)
Figure Global Veterinary Molecular Diagnostics Market Share Forecast by Technology (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by Technology (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by Animal Type (2018-2025)
Figure Global Veterinary Molecular Diagnostics Market Share Forecast by Animal Type (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by Animal Type (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by Disease Indication (2018-2025)
Figure Global Veterinary Molecular Diagnostics Market Share Forecast by Disease Indication (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by Disease Indication (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by End User (2018-2025)
Figure Global Veterinary Molecular Diagnostics Market Share Forecast by End User (2018-2025)
Figure Global Veterinary Molecular Diagnostics Forecast by End User (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|